Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents

Meletios A Dimopoulos; Sosana Delimpasi; Eirini Katodritou; Amalia Vassou; Maria‐Christina Kyrtsonis; Panagiotis Repousis; Zafiris Kartasis; Agapi Parcharidou; Michalis Michael; Eurydiki Michalis; Dimitra Gika; Argiris Symeonidis; Anastasia Pouli; Kostas Konstantopoulos; Evangelos Terpos; Efstathios Kastritis

doi:10.1093/annonc/mdt483

Related publications

Article2012

Significant Improvement of the Survival of Patients with Multiple Myeloma Presenting with Severe Renal Impairment After the Introduction of Novel Agents

Meletios A Dimopoulos, Sosana Delimpasi, Eirini Katodritou, Eleftheria Hatzimichael, Marie‐Christine Kyrtsonis, Panagiotis Repousis, Zafiris Kartasis, Agapi Parcharidou, Michalis Michael, Eurydiki Michalis, Dimitra Gika, Argiris Symeonidis, Konstantinos Zervas, Evangelos Terpos, Efstathios Kastritis

Article2012

Novel Therapeutic Agents for the Management of Patients with Multiple Myeloma and Renal Impairment

Asher Chanan‐Khan, Jesús F. San Miguel, Sundar Jagannath, Heinz Ludwig, Meletios A Dimopoulos

Article2012

The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma

Meletios A Dimopoulos, Μαρία Ρούσσου, Μαρία Γκοτζαμανίδου, Nikitas Nikitas, Erasmia Psimenou, Despoina Mparmparoussi, C. Matsouka, Maria Spyropoulou‐Vlachou, Evangelos Terpos, Efstathios Kastritis

Article2015

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis, Sossana Delimpasis, Argiris Symeonidis, Panagiotis Repousis, Marie‐Christine Kyrtsonis, Chrysa Vadikolia, Eurydiki Michalis, Genovefa Polychronidou, Michalis Michael, Sofia Papadaki, Μαρία Παπαθανασίου, Kyriaki Kokoviadou, Anna Kioumi, Efthymia Vlachaki, Christina Hadjiaggelidou, Alexandra Kouraklis, Ioannis Patsias, Maria Gavriatopoulou, Maria Kotsopoulou,

Article2011

The Role of Novel Agents on Reversibility of Renal Impairment in Newly Diagnosed Patients with Multiple Myeloma; a Single Center Experience on 112 Patients,

Meletios A Dimopoulos, Μαρία Ρούσσου, Μαρία Γκοτζαμανίδου, Erasmia Psimenou, Despoina Mparmparoussi, Charis Matsouka, Evangelos Terpos, Efstathios Kastritis

Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents

Discussion(0)

Related publications

Significant Improvement of the Survival of Patients with Multiple Myeloma Presenting with Severe Renal Impairment After the Introduction of Novel Agents

Novel Therapeutic Agents for the Management of Patients with Multiple Myeloma and Renal Impairment

The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

The Role of Novel Agents on Reversibility of Renal Impairment in Newly Diagnosed Patients with Multiple Myeloma; a Single Center Experience on 112 Patients,